Description

Granisetron Hydrochloride Tablets IP 1 Mg – GRANIVEX 1 Tablets

Composition  – Granisetron 1mg

Description:
GRANIVEX 1 contains Granisetron 1 mg, a selective 5-HT3 receptor antagonist indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative conditions. It works by blocking serotonin receptors involved in triggering the vomiting reflex, providing effective and long-lasting antiemetic protection.

Key Points:

• Potent Antiemetic Action – Effectively prevents and controls nausea and vomiting.
• Selective 5-HT3 Receptor Blockade – Blocks serotonin-mediated emetic signals at both central and peripheral sites.
• Chemotherapy-Induced Nausea & Vomiting (CINV) Control – Provides reliable protection against acute chemotherapy-related emesis.
• Postoperative Nausea & Vomiting (PONV) Management – Helps reduce nausea and vomiting following surgical procedures.
• Long-Lasting Relief – Offers sustained antiemetic efficacy with convenient dosing.

Targeted Specialties:
* Oncology
* General Medicine
* Gastroenterology
* Radiation Oncology

Disclaimer:
To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.